Bronchial Neoplasms  >>  parsatuzumab (RG7414)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
parsatuzumab (RG7414) / Roche
NILE, NCT01366131 / 2011-000711-85: Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease

Completed
2
104
US, Europe, RoW
MEGF0444A, bevacizumab, carboplatin, paclitaxel, placebo
Genentech, Inc.
Non-Squamous Non-Small Cell Lung Cancer
02/13
 

Download Options